Genomic diversity and antimicrobial resistance of Vibrio cholerae isolates from Africa: a PulseNet Africa initiative using nanopore sequencing to enhance genomic surveillance
Authors:
- Ebenezer Foster-NyarkoEbenezer Foster-Nyarko
- Shola Able-ThomasShola Able-Thomas
- Nana Eghele AdadeNana Eghele Adade
- Rexford AdadeRexford Adade
- Jean Claude Blessa AnneJean Claude Blessa Anne
- Loretta AntwiLoretta Antwi
- Yaya BahYaya Bah
- Gifty BoatengGifty Boateng
- Heather CarletonHeather Carleton
- David ChaimaDavid Chaima
- Roma ChilengiRoma Chilengi
- Kalpy Julien CoulibalyKalpy Julien Coulibaly
Open Access
- 5 December 2025
- journal article
- Published by Microbiology Society in Microbial Genomics
- Vol. 11 (12) , 001586
Abstract
Objectives. Vibrio cholerae remains a significant public health threat in Africa, with antimicrobial resistance (AMR) complicating treatment. This study leverages whole-genome sequencing (WGS) of V. cholerae isolates from Côte d’Ivoire, Ghana, Zambia and South Africa to assess genomic diversity, AMR profiles and virulence, demonstrating the utility of WGS for enhanced surveillance within the PulseNet Africa network. Methods. We analysed Vibrio isolates from clinical and environmental sources (2010–2024) using Oxford Nanopore sequencing and hybracter assembly. Phylogenetic analysis, MLST, virulence and AMR gene detection were performed using Terra, Pathogenwatch and Cloud Infrastructure for Microbial Bioinformatics platforms, with comparisons against 118 global reference genomes for broader genomic context. Results. Of 79 high-quality assemblies, 67 were confirmed as V. cholerae , with serogroup O1 accounting for the majority (43 out of 67, 67%). ST69 accounted for 60% (40 out of 67) of isolates, with 8 sequence types identified overall. Thirty-seven isolates formed distinct sub-clades within AFR12 and AFR15 O1 lineages, suggesting local clonal expansions. AMR gene analysis revealed genes associated with resistance to trimethoprim in 96% of isolates and genes associated with resistance to quinolones in 83%, while genes associated with resistance to azithromycin, rifampicin and tetracycline remained low (≤7%). A significant proportion of the serogroup O1 isolates (41 out of 43, 95%) harboured resistance genes in at least 3 antibiotic classes. Conclusions. This study highlights significant genetic diversity and AMR prevalence in African V. cholerae isolates, with expanding AFR12 and AFR15 clades in the region. The widespread presence of genes associated with resistance to trimethoprim and quinolones raises concerns for treatment efficacy, although azithromycin and tetracycline remain viable options. WGS enables precise identification of species and genotyping, reinforcing PulseNet Africa’s pivotal role in advancing genomic surveillance and enabling timely public health responses to cholera outbreaks.Keywords
All Related Versions
This publication has 64 references indexed in Scilit:
- Population genomics implies potential public health risk of two non-toxigenic Vibrio cholerae lineagesInfection, Genetics and Evolution, 2023
- CholeraThe Lancet, 2022
- Structural and DNA-binding properties of the cytoplasmic domain of Vibrio cholerae transcription factor ToxRJournal of Biological Chemistry, 2021
- Antibiotic resistance in Vibrio cholerae: Understanding the ecology of resistance genes and mechanismsVaccine, 2020
- Vibrio cholerae hemagglutinin(HA)/protease: An extracellular metalloprotease with multiple pathogenic activitiesToxicon, 2016
- US Gulf-like toxigenic O1 Vibrio cholerae causing sporadic cholera outbreaks in ChinaJournal of Infection, 2016
- Cholera Outbreaks in Africa2014
- Cholera-like illness due to Aeromonas caviaeIndian Pediatrics, 2013
- CholeraThe Lancet, 2012
- Horizontal Gene Transfers with or without Cell Fusions in All Categories of the Living Matter2011